Price
No data yet.
Social Signal Score
Analyst Ratings
41 analystsRevenue
$1.88B+69.04%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Padraig McDonnell
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Employees
- 18,200
- Beta
- 1.24
- Country
- US
- Piotroski score
- 6 / 9 (Middling)
- Altman Z-score
- 5.83
Financials
Revenue
$1.88B+69.0%Net Income
$362.00M+191.9%EBITDA
$473.00M+109.3%Free Cash Flow
$439.00M+141.2%EPS (diluted)
$1.28+236.8%Shares Outstanding (diluted)
283.00M-13.7%Operating Expenses
$598.00MCash & Debt
$1.76BReturn of Capital
$150.00MRevenue by Segment (annual)
$6.95BDividend per Share
$0.26Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $6.95B | $1.30B | $4.59 |
| 2024 | $6.51B | $1.29B | $4.44 |
| 2023 | $6.83B | $1.24B | $4.22 |
| 2022 | $6.85B | $1.25B | $4.19 |
| 2021 | $6.32B | $1.21B | $3.98 |
| 2020 | $5.34B | $719.00M | $2.33 |
| 2019 | $5.16B | $1.07B | $3.41 |
| 2018 | $4.91B | $316.00M | $0.98 |
| 2017 | $4.47B | $684.00M | $2.12 |
| 2016 | $4.20B | $460.00M | $1.42 |
| 2015 | $4.04B | $401.00M | $1.20 |
| 2014 | $4.05B | $549.00M | $1.65 |
| 2013 | $3.89B | $724.00M | $2.12 |
| 2012 | $6.86B | $1.15B | $3.31 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from A's reported EPS growth of 2.5% a year over 13 years.
- EPS in 5 years
- $5.21
- Implied price
- $166.70
- Return from $172.31
- -0.7% a year
To earn 15.0% a year on these assumptions you'd need to buy at $82.88 — -51.9% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 22 | 27 | 32 | 37 | 42 |
|---|---|---|---|---|---|
| -7.5% | -16.8% | -13.3% | -10.4% | -7.7% | -5.3% |
| -2.5% | -12.3% | -8.7% | -5.5% | -2.7% | -0.2% |
| 2.5% | -7.8% | -4.0% | -0.7% | 2.3% | 4.9% |
| 7.5% | -3.3% | 0.7% | 4.2% | 7.3% | 10.0% |
| 12.5% | 1.2% | 5.4% | 9.0% | 12.2% | 15.1% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
50+66.67%Social Signal Score
Mentions (30)
- Newsseekingalpha.com·3d ago·Neutral
Dividend Champion, Contender, And Challenger Highlights: Week October 4 A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
View source ↗ - Newszacks.com·10d ago·Neutral
Agilent (A) Up 9.6% Since Last Earnings Report: Can It Continue? Agilent (A) reported earnings 30 days ago. What's next for the stock?
View source ↗ - News (Marketaux)finance.yahoo.com·12d ago·Positive
Agilent Technologies Sees Growth From China, Replacement Cycles and Lab Automation Agilent Technologies ([+265 characters]
View source ↗ - Newsseekingalpha.com·12d ago·Positive
Agilent Technologies, Inc. (A) Presents at U.S. All Stars Conference Transcript Agilent Technologies, Inc. (A) Presents at U.S. All Stars Conference Transcript
View source ↗ - Newsmarketbeat.com·13d ago·Positive
Agilent Technologies Sees Growth From China, Replacement Cycles and Lab Automation Agilent Technologies NYSE: A executives outlined continued growth momentum, driven by improving end markets, market-share gains, instrument replacement cycles and operational changes under the company's Ignite transformation program, during a J.P. Morgan conference discussion.
View source ↗ - News (Marketaux)finance.yahoo.com·16d ago·Positive
Agilent (A) Wants Pathology Labs To Go Digital, 540 Slides At A Time On September 4, Agilent Tec[+230 characters]
View source ↗ - Newsbusinesswire.com·19d ago·Neutral
CORRECTING and REPLACING Agilent Announces Cash Dividend of 25.5 Cents per Share SANTA CLARA, Calif.--(BUSINESS WIRE)--First paragraph, second sentence of release should read: The quarterly dividend will be paid on October 28, 2026, to all shareholders of record as of the close of business on October 6, 2026. (instead of The quarterly dividend will be paid on October 6, 2026, to all shareholders of record as of the close of business on October 28, 2026.). The updated release reads: AGILENT ANNOU…
View source ↗ - News (RSS)smh·28d ago·Negative
ASX set to slide as oil prices rise; $A stronger European stocks were weighed down by higher oil prices and a drop in Novartis following the failure of a heart drug, while Wall Street was closed for the Labor Day holiday.
View source ↗ - Newszacks.com·28d ago·Positive
Agilent (A) Upgraded to Buy: What Does It Mean for the Stock? Agilent (A) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
View source ↗ - Newsbusinesswire.com·32d ago·Positive
Agilent Expands Digital Pathology Offering with U.S. Launch of the Agilent S540MD Slide Scanner System SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the U.S. launch of the Agilent S540MD Slide Scanner System, a whole slide imaging (WSI) digital scanner, following FDA clearance. This launch underscores Agilent's ongoing commitment to digital pathology, broadening its portfolio to address the increasing demand for high-throughput solutions in clinical la…
View source ↗ - Newszacks.com·35d ago·Negative
International Markets and Agilent (A): A Deep Dive for Investors Explore how Agilent's (A) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
View source ↗ - News (RSS)yahoo·38d ago·Neutral
Agilent (NYSE) Expanded Non-GAAP Margin 320 bps. How Much Is Repeatable?
View source ↗ - News (Marketaux)gurufocus.com·39d ago·Positive
A Maintained by JP Morgan -- Price Target Raised to $190 Agilent Technologies R[+227 characters]
View source ↗ - News (RSS)investing·39d ago·Negative
Agilent earnings analysis: questions answered and next catalysts
View source ↗ - Newsseekingalpha.com·40d ago·Positive
Agilent Technologies: Q3 Growth, Expanding Margins, And Raised Guidance Agilent Technologies is upgraded to Buy after a strong Q3 2026, with revenue up 8% and EPS up 18% YoY. All three segments posted robust growth, notably Life Sciences and Diagnostics, which saw operating margin jump nearly 600 bps to 23.5%. Guidance for Q4 and FY26 implies continued momentum, with management projecting 6.5–7.5% revenue growth and 8.5% EPS growth for Q4.
View source ↗ - News (RSS)seekingalpha·40d ago·Neutral
Agilent Technologies, Inc. 2026 Q3 - Results - Earnings Call Presentation
View source ↗ - News (Marketaux)gurufocus.com·40d ago·Positive
Agilent Technologies Inc (A) (Q3 2026) Earnings Call Highlights: Strong Core Growth and Raised Guidance Amid Tariff Benefits Positive Points Agilent Te[+197 characters]
View source ↗ - News (RSS)seekingalpha·40d ago·Neutral
Agilent forecasts FY2026 revenue of $7.49B-$7.51B and EPS of $6.18-$6.21 as China returns to 9% growth
View source ↗ - News (RSS)seekingalpha·40d ago·Positive
Agilent Technologies, Inc. (A) Q3 2026 Earnings Call Transcript
View source ↗ - Newsseekingalpha.com·40d ago·Positive
Agilent Technologies, Inc. (A) Q3 2026 Earnings Call Transcript Agilent Technologies, Inc. (A) Q3 2026 Earnings Call Transcript
View source ↗ - Newsmarketbeat.com·40d ago·Neutral
Agilent Technologies Q3 Earnings Call Highlights Agilent Technologies NYSE: A reported third-quarter fiscal 2026 revenue of $1.88 billion, with core revenue growth of 7.3%, exceeding the high end of its guidance range. The company said earnings per share were $1.56 excluding tariff-refund benefits, up 14% from a year earlier and $0.06 above the top of its guided range.
View source ↗ - Newszacks.com·40d ago·Neutral
Agilent (A) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates The headline numbers for Agilent (A) give insight into how the company performed in the quarter ended July 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
View source ↗ - Newszacks.com·40d ago·Positive
Agilent Technologies (A) Q3 Earnings and Revenues Top Estimates Agilent Technologies (A) came out with quarterly earnings of $1.62 per share, beating the Zacks Consensus Estimate of $1.48 per share. This compares to earnings of $1.37 per share a year ago.
View source ↗ - Newsreuters.com·40d ago·Negative
Agilent raises annual profit forecast on improving lab tools demand Agilent Technologies raised its annual profit forecast on Wednesday, betting on improving demand for its medical tools and equipment used in lab research and drug development.
View source ↗ - Newszacks.com·41d ago·Positive
Agilent Technologies (A) is a Great Momentum Stock: Should You Buy? Does Agilent Technologies (A) have what it takes to be a top stock pick for momentum investors? Let's find out.
View source ↗ - News (RSS)smh·43d ago·Negative
ASX set to rise as Wall Street advances; $A, bitcoin stronger US stocks rose and trimmed their losses from a shaky week. That was even though the bond market, which has been the centre of Wall Street’s action, remained jumpy and continued to add pressure.
View source ↗ - News (RSS)investing·45d ago·Neutral
Agilent Technologies stock hits 52-week high at 160.36 USD
View source ↗ - Newszacks.com·45d ago·Neutral
Exploring Analyst Estimates for Agilent (A) Q3 Earnings, Beyond Revenue and EPS Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Agilent (A), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended July 2026.
View source ↗ - News247wallst.com·45d ago·Negative
Agilent Stock Has A Catalyst Coming On August 26 That Investors Should Not Ignore Agilent Technologies (NYSE:A | A Price Prediction) heads into a pivotal earnings setup for retirement-oriented portfolios, with a company-confirmed Q3 2026 report after the close on Aug.
View source ↗ - Newsdefenseworld.net·52d ago·Negative
Agilent Technologies, Inc. $A Stock Position Decreased by Assenagon Asset Management S.A. Assenagon Asset Management S.A. trimmed its stake in Agilent Technologies, Inc. (NYSE: A) by 75.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 10,454 shares of the medical research company's stock after selling 31,934 shares during the quarter. Assenagon Asset Management S.A.'s
View source ↗
Earnings
Mon, Nov 23(in 7 weeks)
Consensus estimate $1.72 per share
Typical surprise +2.3% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Aug 26$1.62 vs $1.49beat
- Wed, May 27$1.49 vs $1.41beat
- Wed, Feb 25$1.36 vs $1.37miss
- Mon, Nov 24$1.59 vs $1.58beat
- Wed, Aug 27$1.37 vs $1.37beat
- Wed, May 28$1.31 vs $1.26beat
Estimates and results for A via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by A officers and directors.
- Bought
- —
- Sold
- $3.8m
0 trades
10 trades
- Dolsten Mikaelsold
- Dolsten Mikaelsold
- Dolsten Mikaelsold
- Gonsalves Rodneysold
- Mcdonnell Padraigsold
- Mcdonnell Padraigsold
- Mcdonnell Padraigsold
- Mcdonnell Padraigsold
90 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Julie Johnsonhouse · TX32 · disclosed Aug 6, 2026 (317d later)Buy$1,001 - $15,000
- Julie Johnsonhouse · TX32 · disclosed Aug 6, 2026 (317d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Feb 10, 2026 (12d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Oct 3, 2025 (4d later)Buy$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Aug 13, 2025 (57d later)Buy$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Aug 13, 2025 (28d later)Sell$1,001 - $15,000
- Jefferson Shrevehouse · IN06 · disclosed Jun 23, 2025 (42d later)Sell$15,001 - $50,000
- Robert P. Bresnahanhouse · PA08 · disclosed Jun 2, 2025 (18d later)Buy$1,001 - $15,000
- Julie Johnsonhouse · TX32 · disclosed May 15, 2025 (44d later)Sell$1,001 - $15,000
- Jefferson Shrevehouse · IN06 · disclosed May 9, 2025 (22d later)Buy$15,001 - $50,000
- Robert P. Bresnahanhouse · PA08 · disclosed Apr 29, 2025 (21d later)Sell$1,001 - $15,000
- Julie Johnsonhouse · TX32 · disclosed Apr 15, 2025 (43d later)Sell$1,001 - $15,000
- Jefferson Shrevehouse · IN06 · disclosed Apr 14, 2025 (32d later)Sell$15,001 - $50,000
- Ro Khannahouse · CA17 · disclosed Nov 11, 2024 (28d later)Buy$1,001 - $15,000
- Thomas Hawley Tubervillesenate · AL · disclosed Jun 14, 2024 (42d later)Sell$1,001 - $15,000
- Thomas Hawley Tubervillesenate · AL · disclosed May 15, 2024 (40d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Dec 6, 2023 (33d later)Buy$1,001 - $15,000
- Thomas Hawley Tubervillesenate · AL · disclosed Nov 16, 2023 (31d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Nov 8, 2023 (37d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Nov 8, 2023 (8d later)Buy$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.